2014 annual financial data
Atossa Therapeutics 2014 Operating margin
Direct answer
Operating margin was -30,322.96%.
Operating income was -12,171,028 USD and net income was -14,657,926 USD.
Operating cash flow was -10,555,450 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,138 USD
- Operating income
- -12,171,028 USD
- Net income
- -14,657,926 USD
- Operating cash flow
- -10,555,450 USD